desoxycorticosterone has been researched along with bw 723c86 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fink, GD; Watts, SW | 1 |
Watts, SW | 1 |
Banes, AK; Watts, SW | 1 |
3 other study(ies) available for desoxycorticosterone and bw 723c86
Article | Year |
---|---|
5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Desoxycorticosterone; Gastric Fundus; Gastrointestinal Motility; Hypertension; Indoles; Male; Mesenteric Arteries; Organic Chemicals; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sodium Chloride; Thiophenes; Time Factors; Vasoconstriction | 1999 |
Serotonin-induced contraction in mesenteric resistance arteries: signaling and changes in deoxycorticosterone acetate-salt hypertension.
Topics: Animals; Carbazoles; Desoxycorticosterone; Dose-Response Relationship, Drug; Fluorobenzenes; Hypertension; In Vitro Techniques; Indoles; Ketanserin; Male; Mesenteric Arteries; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Signal Transduction; Sumatriptan; Thiophenes; Vascular Resistance; Vasoconstriction | 2002 |
Arterial expression of 5-HT2B and 5-HT1B receptors during development of DOCA-salt hypertension.
Topics: Animals; Arteries; Desoxycorticosterone; Female; Gene Expression; Hypertension; Indoles; Male; Pyridines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT2B; Serotonin Antagonists; Serotonin Receptor Agonists; Sodium Chloride; Thiophenes; Vasoconstriction | 2003 |